# Brief Intervention to Reduce Fear of Public Speaking

> **NCT02790736** · PHASE4 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 6 (actual)

## Conditions studied

- Social Anxiety Disorder

## Interventions

- **DRUG:** propranolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02790736
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-10-30
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** COVID-19 restrictions
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02790736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02790736, "Brief Intervention to Reduce Fear of Public Speaking". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02790736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*